Clinical and Radiographic Evaluation of the Effect of Hyaluronic Acid Surface Treatment Versus Sandblasted Acid Etched on Stability of Delayed Dental Implant in Posterior Maxilla.

Bone Loss Clinical Trial

Official title:
Clinical and Radiographic Evaluation of the Effect of Hyaluronic Acid Surface Treatment Versus Sandblasted Acid Etched Surface Treatment on Stability of Delayed Dental Implant in Posterior Maxilla. Comparative Randomized Clinical Trial (RCT).

Status Not yet recruiting

Clinical Trial Summary

Clinical Trial Description

A dental implant is one of the procedures to restore missing teeth , to achieved the stability for implant success is the direct growth of bone to the implant surface, known as Osseointegration.As a result, bone stability around dental implants is determined by factors that the implantologist may or may not directly influence, such as local bone quality and bone metabolism, as well as systemic factors such as age, systematic chronic diseases and lifestyle (e.g., smoking habits).Treatment-related factors include augmentation material, implant design (macro and micro), surgical procedures, and loading protocols. Therefore , it may be needed for a surface treatment could alter the topography, chemical content, and roughness of the surface and result in various biological reactions. The surface treatment can also increase the area of contact between the implant and the supporting bone . The rationale is evaluate Increasing the implant stability around implants placed by using hyaluronic acid that act to improving the connection between implant and bone .Sandblasting and acid etching is the most commonly used basic method for modifying the surface of dental implants . the sandblasting procedure "roughs up" the outer layer of the implant,creating a surface that is easier for the bone to grip as the implant heals.While hyaluronic acid and its derivatives have a strong chance of osseointegration and mineralization and have been utilized extensively for bone repair. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06033989
Study type	Interventional
Source	Cairo University
Contact	Shihanah Alkashi, BSc
Phone	00966542044424
Email	Shihanah.yousef@dentistry.cu.edu.eg
Status	Not yet recruiting
Phase	N/A
Start date	October 1, 2023
Completion date	January 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04043286` - The Effects of Dis/Reconnection of Implant Abutments on Peri-implant Bone Levels	N/A
Recruiting	`NCT03046147` - The Effect of Roux-en-Y Gastric Bypass on Bone Turnover	N/A
Completed	`NCT01292395` - Effects of Dietary Protein on Musculoskeletal Health During Calorie Deficiency	N/A
Completed	`NCT00485953` - Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy	Phase 4
Completed	`NCT00674453` - The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation	Phase 2
Completed	`NCT00181584` - Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer	Phase 2
Withdrawn	`NCT04380155` - Cycling Duration and Bone Markers in in Active Young Adults	N/A
Active, not recruiting	`NCT04779216` - Effects of Romosozumab on Bone Density in Women With Anorexia Nervosa	Phase 3
Completed	`NCT05371418` - Comparative Clinical and Radiographical Evaluation of Treatment of Angular Bone Defect Related to Over Erupted Tooth Using GTR Followed by Orthodontic Intrusion Versus Orthodontic Intrusion Followed by GTR	N/A
Not yet recruiting	`NCT04345250` - Bone Response to Exercise and Energy Restriction in Young Adults	N/A
Active, not recruiting	`NCT05301400` - Marginal Bone Loss in Single Implant Restaurations With Different Methods	N/A
Active, not recruiting	`NCT05405894` - Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation
Recruiting	`NCT04983758` - 20-year Implant Survival in Periodontally Healthy and Compromised Patients
Recruiting	`NCT04713774` - Bone Density and Vascular Calcifications Evolution After Renal Transplant
Completed	`NCT04279392` - Healthy Body, Healthy Bones After Bariatric Surgery Trial	Phase 1/Phase 2
Completed	`NCT04332679` - Non-resorbable Membranes Versus Titanium Meshes and Resorbable Membranes	N/A
Completed	`NCT05721014` - Effects of OsteoStrong vs. Individually Adapted and Combined Training on Bone Health	N/A
Recruiting	`NCT04883502` - Study of the Role of the Induced Membrane in the Reconstruction of Bone Loss in the Limbs
Not yet recruiting	`NCT05066815` - Evaluation of Crestal Bone Loss Around Short Dental Implants As Affected By Two Suprastructure Materials	N/A
Completed	`NCT03292146` - Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.